SCHEMBL14000340

SCHEMBL14000340

O=P(c1ccccc1)(c1ccccc1)c1cccc(P(=O)(c2ccccc2)c2ccccc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.43
RECQL P46063 1/20 0.43
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA5A P35218 1/20 0.42
NPSR1 Q6W5P4 3/20 0.40
LMNA P02545 1/20 0.39
CFTR P13569 1/20 0.38
MAPT P10636 2/20 0.37
GAA P10253 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 1/20 0.37
ALPG P10696 1/20 0.37
ALOX12 P18054 1/20 0.37
NPY1R P25929 1/20 0.37
NPY2R P49146 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9927376 0.89 FBP1 (0.41) HTTRECQLCA2CA4CA5A
SCHEMBL11991065 0.87 MEN1 (0.41) HTTRECQLCA2CA4CA5A
SCHEMBL18092523 0.86 ALDH1A1 (0.38) HTTRECQLCA2CA4CA5A
SCHEMBL16161410 0.86 CYP3A4 (0.39) HTTRECQLCA2CA4CA5A
SCHEMBL31619841 0.86 ALDH1A1 (0.38) HTTRECQLCA2CA4CA5A
SCHEMBL11991097 0.82 CA2 (0.39) HTTRECQLCA2CA4CA5A
SCHEMBL16161519 0.81 ALDH1A1 (0.38) HTTRECQLCA2CA4CA5A
SCHEMBL14020790 0.81 KDM4E (0.45) HTTRECQLCA2NPSR1LMNA
SCHEMBL11991069 0.81 MEN1 (0.45) HTTRECQLNPSR1LMNAMAPT
SCHEMBL11991110 0.80 NPSR1 (0.40) HTTRECQLCA2CA4CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112250654-B Method for preparing oxabicyclohexadecene 万华化学集团股份有限公司(CN) 2023-01-13 CN claimed
CN-112250654-A Method for preparing oxabicyclo hexadecene 万华化学集团股份有限公司 2021-01-22 CN claimed
CN-112250654-B Method for preparing oxabicyclohexadecene 万华化学集团股份有限公司(CN) 2023-01-13 CN disclosed
CN-112250654-B Method for preparing oxabicyclohexadecene 万华化学集团股份有限公司(CN) 2023-01-13 CN disclosed
EP-3249714-B1 SEMICONDUCTING MATERIAL COMPRISING AZA-SUBSTITUTED PHOSPHINE OXIDE MATRIX AND METAL SALT NOVALED GMBH (DE) 2021-03-17 EP disclosed
CN-112250654-A Method for preparing oxabicyclo hexadecene 万华化学集团股份有限公司 2021-01-22 CN disclosed
US-10727415-B2 Phosphine-based compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-28 US disclosed
US-20190019959-A1 PHOSPHINE-BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-01-17 US disclosed
EP-3249714-A1 SEMICONDUCTING MATERIAL COMPRISING AZA-SUBSTITUTED PHOSPHINE OXIDE MATRIX AND METAL SALT Novaled GmbH (DE) 2017-11-29 EP disclosed
US-20160111654-A1 Semiconducting Material Comprising Aza-Substituted Phosphine Oxide Matrix and Metal Salt NOVALED GMBH (DE) 2016-04-21 US disclosed
US-20160111654-A1 Semiconducting Material Comprising Aza-Substituted Phosphine Oxide Matrix and Metal Salt NOVALED GMBH (DE) 2016-04-21 US disclosed
US-20080286610-A1 HYBRID OLED WITH FLUORESCENT AND PHOSPHORESCENT LAYERS GLOBAL OLED TECHNOLOGY LLC 2008-11-20 US disclosed
US-20080241589-A1 ORGANIC ELECTROLUMINESCENT DEVICE FUJIFILM CORPORATION (JP) 2008-10-02 US disclosed
US-20080241589-A1 ORGANIC ELECTROLUMINESCENT DEVICE FUJIFILM CORPORATION (JP) 2008-10-02 US disclosed
US-20080238307-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT FUJIFILM CORPORATION (JP) 2008-10-02 US disclosed
US-20080238307-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT FUJIFILM CORPORATION (JP) 2008-10-02 US disclosed
US-20080241518-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT UDC IRELAND LIMITED (IE) 2008-10-02 US disclosed
US-20080241518-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT UDC IRELAND LIMITED (IE) 2008-10-02 US disclosed
US-7419728-B2 Light-emitting device containing bis-phosphineoxide compound EASTMAN KODAK COMPANY (US) 2008-09-02 US disclosed
US-7419728-B2 Light-emitting device containing bis-phosphineoxide compound EASTMAN KODAK COMPANY (US) 2008-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080241589-A1 ORGANIC ELECTROLUMINESCENT DEVICE OR10J3, AOC2, L1CAM HTT 4573/4885RECQL 2665/4885CA2 1811/4885
US-10727415-B2 Phosphine-based compound and organic electroluminescence device including the same PHOSPHO1, PEF1, ODC1 HTT 4236/4885RECQL 2111/4885CA2 1898/4885
US-20190019959-A1 PHOSPHINE-BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME PHOSPHO1, PEF1, ODC1 HTT 4236/4885RECQL 2111/4885CA2 1898/4885
US-20160111654-A1 Semiconducting Material Comprising Aza-Substituted Phosphine Oxide Matrix and Metal Salt AZI2, ITPA, TET3 HTT 2798/4885RECQL 3347/4885CA2 817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.